Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Decreases By 98.6%

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 800 shares, a decrease of 98.6% from the January 15th total of 58,800 shares. Based on an average daily volume of 5,800 shares, the short-interest ratio […]

Related Keywords

,Wells Fargo Company ,Renaissance Technologies ,Nasdaq ,Gt Biopharma Company Profile ,Gt Biopharma Inc ,Atria Wealth Solutions Inc ,Get Free Report ,Stock Down ,Wealth Solutions ,Street Group ,Tri Specific Killer Engager ,Gt Biopharma ,Nasdaq Gtbp ,Gtbp ,Medical ,Stocks ,Options ,Put ,Call ,